Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Michael Glynn

Premium

Michael Glynn has resigned as Pacific Biosciences' chief commercial officer. Glynn joined PacBio in October 2011 from Genzyme, where he served as regional president of Japan-Asia Pacific and senior vice president. He also held various roles at Boston Scientific and was CEO of Codman Group, a developer of healthcare decision support software and home telemedicine systems. He holds an MBA from Macquarie University in Sydney and a BS from the National University of Ireland.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.